Comparing a cosmetic product for treating facial acne in young adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a cosmetic product as complementary care alongside a prescribed topical medical treatment for facial acne in teenagers and young adults. Participants will undergo a 3-month associated treatment phase followed by a 3-month maintenance phase, during which the cosmetic product will be compared to a light moisturizing cream. The study aims to assess both the global benefits and the tolerance of the tested product in conjunction with the medical treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or Female aged between 14 and 24 years (included)
* Subject with facial acne with score index severity IGA = 2 or 3, assessed on a scale ranged from 0 to 4.
* Subject for whom a prescription of 12 weeks of a reference topical medical treatment is required from the day of the inclusion visit, for mild to moderate face acne

Exclusion Criteria:

Criteria related to the disease:

* Facial skin disease other than acne, skin abnormalities, or dermatological condition on the face liable to interfere with the study assessments
* Acne conglobata, Acne fulminans, nodulocystic acne or acneiform eruptions, according to investigator's assessment
* Other type of pigmentation disorder than acne-related PIH liable to interfere with the study assessments according to the investigator

Criteria related to treatments and/or products:

\- Topical or oral treatment established or modified during the previous weeks or planned to be established or modified during the study, liable to interfere with the evaluation of the efficacy or cutaneous tolerance of the investigational products

Where it's running

• Unifesp
  São Paulo, Brazil Recruiting

Study contacts

• Study coordinator: Adeline Bacquey
• Email: adeline.bacquey@pierre-fabre.com
• Phone: +33562877753

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adapalene/Clindamycin Gel in Vietnamese Acne Patients

  This study tests how safe and tolerable and how well Klenzit-C works when used in routine care by Vietnamese patients aged 12 and up with mild to moderate acne.

  Recruiting at 2 sites Phase 4 Ir Innovate Research Private Limited · Hanoi and 2 other locations · NCT07918001

• Skincare regimen for mild to moderate acne in people with sensitive skin

  A 4-week test will check if a skincare regimen helps with mild to moderate acne in adults with sensitive skin.

  Recruiting USMARI Research & Innovation Centre · Petaling Jaya, Selangor · NCT07749469

• Engineered Lactobacillus reuteri cream with zinc sulfate–tannic acid MPN coating for acne

  This trial will test whether a topical cream containing engineered Lactobacillus reuteri with a zinc sulfate–tannic acid coating can reduce inflammatory acne in adults aged 18–33.

  Recruiting Phase 2 Shenzhen People's Hospital · Shenzhen, Guangdong · NCT07366229

• Probiotic drink for skin inflammation during the menopausal transition

  This study will test whether a daily Lactobacillus casei Shirota probiotic drink can reduce inflammation and improve immune and skin health in women aged 40–60 going through the menopausal transition with inflammatory facial skin conditions.

  Recruiting King's College London · London, London · NCT07341087

• Acne mRNA vaccine for adults with mild facial acne

  This trial will test two injections of an acne mRNA vaccine versus placebo in adults 18–45 with mild facial acne to see if it's safe, triggers an immune response, and improves acne.

  Recruiting at 4 sites Phase 1/2 Sanofi · Encino, California and 3 other locations · NCT07013747

• Evaluating the safety and effects of TVB-3567 in healthy individuals and those with acne

  This study is testing a new drug called TVB-3567 to see how safe it is and how it works in healthy people and those with acne.

  Recruiting at 3 sites Phase 1 Sagimet Biosciences Inc. · Tempe, Arizona and 5 other locations · NCT06989840

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.